Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis

Post-Coronary Artery Bypass Grafting Outcomes of Patients with/without Type-2 Diabetes Mellitus and Chronic Kidney Disease Treated with SGLT2 Inhibitor Dapagliflozin: A Single-Center Experience Analysis

Introduction: Increasingly, SGLT2 inhibitors save patients with heart failure and comorbidities such as type-2 diabetes mellitus (T2DM) and chronic kidney disease (CKD); the inhibition of sodium-glucose cotransporter 2 (SGLT2) was first studied in patients with diabetes as a solution to lower glucos...

Full description

Bibliographic Details
Main Authors: Razan Al Namat, Letiția Doina Duceac, Liliana Chelaru, Marius Gabriel Dabija, Cristian Guțu, Constantin Marcu, Maria Valentina Popa, Florina Popa, Elena Roxana Bogdan Goroftei, Elena Țarcă
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Diagnostics
Subjects:
CABG
heart failure
SGLT2 inhibitors
type-2 diabetes mellitus
H-FABP
Online Access:https://www.mdpi.com/2075-4418/14/1/16

Internet

https://www.mdpi.com/2075-4418/14/1/16

Similar Items